Semaglutide targets the GLP-1 incretin receptor, while tirzepatide engages with both GLP-1 and GIP incretin receptors. Research suggests that tirzepatide may result in more substantial weight loss compared to semaglutide. Additionally, patients often report experiencing fewer gastrointestinal symptoms such as nausea, diarrhea, or constipation with tirzepatide. During the complimentary initial consultation, both treatment options will be thoroughly discussed. This ensures that patients are fully informed and empowered to make the choice that best aligns with their individual needs and preferences.

These medications are commonly prescribed for adults with a BMI (Body Mass Index) of 30 or higher, or individuals with a BMI of 27 or higher who have at least one weight-related health condition, such as type 2 diabetes, high blood pressure, or high cholesterol. However, it's important to note that BMI isn't always a definitive indicator, and treatment decisions aren't solely based on this metric. Instead, healthcare providers assess each patient's overall health status, medical history, and individual needs to determine the most appropriate course of action.

Weight loss outcomes can vary significantly from person to person and are influenced by various factors. Clinical trials have demonstrated that when combined with a balanced diet and regular exercise, semaglutide and tirzepatide can lead to substantial weight loss. On average, patients may experience a reduction of 5-10% of their initial body weight over a 12-week period, although individual results may vary. It's important to note that healthy weight loss is typically considered to be in the range of 1-2 pounds per week. However, the specific rate of weight loss can depend on factors such as metabolic rate, adherence to the treatment plan, lifestyle factors, and individual physiology.

Semaglutide is commonly administered as a once-weekly injection beneath the skin (subcutaneously). The dosage prescribed may vary depending on individual patient requirements and tolerability. It's essential for patients to follow their healthcare provider's instructions carefully regarding the timing and administration of semaglutide injections to optimize treatment outcomes. Regular communication with healthcare professionals can facilitate adjustments to the dosage regimen as needed to support each patient's weight loss journey effectively.

Your medication will be sourced from a reputable compounding pharmacy. These pharmacies adhere to stringent standards and regulations, ensuring the preparation of medications in sterile environments. They are either licensed by their State Board of Pharmacy or FDA-licensed facilities, guaranteeing the safety and quality of the medications provided. Utilizing compounding pharmacies allows us to offer you the necessary medication for your treatment without the exorbitant costs associated with brand-name versions. This approach ensures accessibility to high-quality treatment options while prioritizing affordability for our patients.

The following are contraindications for semaglutide/tirzepatide. Which will make the individual
ineligible for this treatment.
● Medullary Thyroid Carcinoma OR Family History
● MEN 2 (Multiple Endocrine Neoplasia syndrome type 2)
● Hypersensitivity
● Diabetes Type 1
● Current Suicidal Ideation
● Pancreatitis
● Pregnancy and Breastfeeding